ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.582,49
0,51%
S&P 500
5.187,67
0,00%
Dow Jones
39.056,39
0,44%
Euro vs US Dollar
1,0732
-0,14%
Bitcoin
60.937,08
-0,41%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. EPIRUS Biopharmaceuticals Inc (CE) (EPRSQ)

  7. EPIRUS Biopharmaceuticals Inc (CE) (EPRSQ) News

EPRSQ

EPIRUS Biopharmaceuticals (CE) (EPRSQ)

EPIRUS Biopharmaceuticals Inc (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:EPRSQ
DatumZeitQuelleÜberschriftSymbolFirma
14/02/201718h06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
26/09/201615h34Edgar (US Regulatory)(25-NSE)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
01/08/201619h41Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
25/07/201617h32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
11/07/201620h57Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
11/07/201618h10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
08/07/201617h03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
01/07/201623h23Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
14/06/201622h07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
31/05/201622h54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
31/05/201622h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
31/05/201622h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
31/05/201622h52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
10/05/201623h51Edgar (US Regulatory)Quarterly Report (10-q)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
09/05/201623h20Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
09/05/201622h00GlobeNewswire Inc.EPIRUS Announces Reprioritization of Pipeline to Solely Focus on Biosimilars to Treat Rare Diseases and Key Leadership Change...USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
29/04/201613h01Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
29/03/201622h07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
29/03/201612h10Edgar (US Regulatory)Annual Report (10-k)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
15/03/201621h38Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
15/03/201611h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
15/03/201611h00GlobeNewswire Inc.EPIRUS Biopharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financial Results and Provides Business UpdateUSOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
11/03/201622h08Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
10/03/201601h46GlobeNewswire Inc.EPIRUS Biopharmaceuticals to Release Fourth Quarter and Fiscal Year 2015 Financial Results and Provide Business UpdateUSOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
01/03/201622h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
01/03/201622h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
01/03/201622h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
01/03/201622h14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
01/03/201614h11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
01/03/201612h11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:EPRSQ

Kürzlich von Ihnen besucht

CCOM
US500
US 500
TG
BAS
BASF
TG
DBK
Deutsche Bank
NASDAQ
TSLA
Tesla
CCOM
US30
US 30
TG
RHM
Rheinmetall
DBI
SDXP
SDAX
NYSE
XOM
Exxon Mobil
DBI
TDXP
Tec DAX
USOTC
DTEGY
Deutsche Telekom (QX)
TG
NOV
Novo Nordisk
TG
MBG
MercedesBenz
NYSE
NKE
Nike
TG
DTE
Deutsche Telekom
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten